Category

Investment Banking

Nordic Nanovector
Investment Banking

Nordic Nanovector

Nordic Nanovector ASA, and all shareholders of APIM Therapeutics, a privately held, clinical-stage cancer-focused biotechnology company,...

KMC Properties
Investment Banking

KMC Properties

Carnegie Investment Bank is proud to have acted as joint bookrunner and manager in connection with...

PGS
Investment Banking

PGS

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in PGS’ successful NOK 1,536 million...

Norway Royal Salmon and SalMar
Investment Banking

Norway Royal Salmon and SalMar

Norway Royal Salmon ASA and SalMar (the “Parties”) have on 31 October 2022 announced that the Parties have...

SalMar and NTS
Investment Banking

SalMar and NTS

SalMar has on 31 October 2022 announced that the closing conditions of its voluntary offer for...

Cloudberry Clean Energy
Investment Banking

Cloudberry Clean Energy

Carnegie Investment Bank is proud to have acted as Joint Global Coordinator in connection with the...

Agilyx
Investment Banking

Agilyx

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with the NOK...

Holzweiler
Investment Banking

Holzweiler

Carnegie is proud to have acted as financial advisor to Holzweiler and its owners in connection with...

DOF Subsea
Investment Banking

DOF Subsea

Carnegie Investment Bank is proud to have acted as financial advisor to an ad hoc group...

Nykode Therapeutics
Investment Banking

Nykode Therapeutics

Carnegie Investment Bank congratulates Nykode Therapeutics on their uplisting of the Company’s shares to the main list of...

Vår Energi
Investment Banking

Vår Energi

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with the NOK...

Norway Royal Salmon
Investment Banking

Norway Royal Salmon

Carnegie Investment Bank congratulates Norway Royal Salmon with the proposed merger with SalMar.  The merger will...